#COVID-19 vaccine

Public health officials are recommending that people upgrade from their cloth masks to higher-quality medical-grade masks.

The Supreme Court has overturned the OSHA rule that says large companies must require either vaccination or masks and regular testing.

Fatty liver disease dominated the Hep science news this year, but COVID-19 remains a concern for people with liver disease.

Paxlovid, which reduces the risk of hospitalization or death by about 90%, is expected to be a game-changer.

It’s been more than six months since many Americans finished their COVID-19 vaccination series, and their immunity may be waning.

Older and immunocompromised people and those with underlying health conditions could benefit most from additional shots.

Boosters further reduce the risk of severe illness and can help curb coronavirus transmission.

Post-exposure and pre-exposure prophylaxis could be a game-changer for immunocompromised people.

Vaccine effectiveness for children ages 5 to 11 was 91%, and serious side effects are rare.

Powell had received treatment for multiple myeloma, which can lead to poorer response to COVID-19 vaccines.

Co-occurring health disorders appear to contribute to increased risk, NIH study suggests.

A growing number of transplant programs are barring patients who refuse COVID vaccines or giving them lower priority on waiting lists.

The Damien Center in Indianapolis adds clean syringes to its harm reduction, HIV and hepatitis C efforts.

Collins has led the NIH under three presidents over more than 12 years.

A steady stream of spurious claims about COVID-19 vaccines and treatments swirl around the public consciousness.

I’d put my breakthrough case of COVID right up there with my worst bouts of flu.